Femasys Quote - FEMY

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.09

Bid

1.08

Ask

1.17

Volume

0.00 Day's Range 0.00

0.734 52 Week Range 2.40

Market Cap

24.234M

Previous Close

1.09

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

136,285

Shares Outstanding

22,232,799

Dividend Yield

PE Ratio

-1.70

Earnings Per Share (EPS)

-0.64

Revenue

1.07M

Net Profit

-14.25M

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in... Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.femasys.com

Headquarters

Dover, Delaware, USA

Founded

Femasys Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker FEMY. The last closing price for Femasys was US$1.09. Over the last year, Femasys shares have traded in a share price range of US$ 0.734 to US$ 2.40.

Femasys currently has 22,232,799 shares outstanding. The market capitalization of Femasys is US$24.23 million. Femasys has a price to earnings ratio (PE ratio) of -1.70.

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-1.8018018018	1.11	1.15	1.07	119274	1.10984037	CS
4	-0.03	-2.67857142857	1.12	1.22	1.05	97616	1.12286595	CS
12	0	0	1.09	1.29	0.86	136285	1.08358425	CS
26	-0.21	-16.1538461538	1.3	1.51	0.86	161851	1.16840428	CS
52	-0.27	-19.8529411765	1.36	2.4	0.734	507052	1.30284177	CS
156	-6.25	-85.1498637602	7.34	8.1	0.2479	1347532	1.84567111	CS
260	-11.99	-91.6666666667	13.08	13.75	0.2479	1228383	1.91449423	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TVGNTevogen Bio Holdings Inc	US$ 0.8257 (117.52%)	3.46M
TOIIWOncology Institute Inc	US$ 0.035 (73.27%)	118
XPONExpion360 Inc	US$ 4.13 (72.80%)	1.76M
RANIRani Therapeutics Holdings Inc	US$ 2.57 (27.23%)	294.14k
SGDSafe and Green Development Corporation	US$ 4.66 (25.61%)	531.75k
MTEMMolecular Templates Inc	US$ 0.3694 (-74.87%)	397.58k
ZPTAZapata Computing Holdings Inc	US$ 0.079 (-69.73%)	2.36M
VEVVicinity Motor Corporation	US$ 0.0668 (-42.95%)	517.18k
VCNXVaccinex Inc	US$ 1.50 (-26.11%)	1
IBGInnovation Beverage Group Limited	US$ 0.80 (-20.00%)	20
CETXCemtrex Inc	US$ 0.5131 (17.95%)	5.01M
JTAIJet AI Inc	US$ 0.1118 (10.69%)	4.45M
TVGNTevogen Bio Holdings Inc	US$ 0.826 (117.60%)	3.46M
BJDXBluejay Diagnostics Inc	US$ 0.1184 (2.25%)	2.53M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9.71 (3.30%)	2.44M